After blueprinting an injectables facility in North Carolina in 2020, it didn’t take long for Eli Lilly to draw up designs ...

The locally-backed projects on the Trump Effect list include Diageo, a British alcoholic beverage company, whose $415 million ...

Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP ...

Eli Lilly (NYSE:LLY) announced today that it plans to invest an additional $450 million at a North Carolina manufacturing facility.. Lilly expects the investment to create at least 100 new jobs at the ...

Touchstone and Rowley highlight why companies like Eli Lilly, Novo Nordisk, and Genentech are choosing to set up shop in ...

Eli Lilly and Co. said Tuesday it plans to invest another $450 million at a factory in North Carolina that makes diabetes medicines and devices. The move will create at least 100 new jobs at the ...

A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S. Eli Lilly tags Triangle for long-term growth 2024 Space Awards: Economic ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

North Carolina officials are urging the Biden administration to negotiate licenses for Novo Nordisk's and Eli Lilly's obesity drugs so lower-cost alternatives can be made available.

He’s invested nearly $50 billion since 2020 in expanding and building four new Lilly manufacturing facilities in the U.S., including in North Carolina, Wisconsin, and Indianapolis.

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.